BioLargo, Inc. (BLGO)
OTCMKTS · Delayed Price · Currency is USD
0.1100
-0.0087 (-7.33%)
Jul 23, 2026, 3:34 PM EST
BioLargo Revenue
BioLargo had revenue of $1.12M in the quarter ending March 31, 2026, a decrease of -65.89%. This brings the company's revenue in the last twelve months to $5.61M, down -65.55% year-over-year. In the year 2025, BioLargo had annual revenue of $7.77M, down -56.32%.
Revenue (ttm)
5.61M
Revenue Growth
-65.55%
P/S Ratio
6.59
Revenue / Employee
124.69K
Employees
46
Market Cap
36.96M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.77M | -10.01M | -56.32% |
| Dec 31, 2024 | 17.78M | 5.55M | 45.37% |
| Dec 31, 2023 | 12.23M | 6.35M | 107.85% |
| Dec 31, 2022 | 5.88M | 3.35M | 132.48% |
| Dec 31, 2021 | 2.53M | 99.00K | 4.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cardinal Ethanol, LLC | 350.34M |
| NuEarth | 15.34M |
| Vulcan International | 5.35M |
| Lithium & Boron Technology | 2.47M |
| American Green Group | 688.17K |
| Angstrom Technologies | 642.35K |
| Energy and Environmental Services | 314.71K |
| Green Bridge Industries | -87.84K |
BioLargo News
- 10 days ago - BioLargo preparing to relaunch CupriDyne-based consumer products - TheFly
- 10 days ago - BioLargo Relaunching CupriDyne(R)-Based Consumer Products - Back by Popular Demand and Generated More than $125 Million in Pet-Care Sales - Accesswire
- 22 days ago - BioLargo Engineering Unit Awarded $1.4 Million in U.S. Air Force Environmental Contract Renewals - Accesswire
- 2 months ago - BioLargo Quarterly report: Q1 2026 - Filings
- 2 months ago - BioLargo Transcript: Status update - Transcripts
- 2 months ago - BioLargo Subsidiary Clyra Medical Signs Exclusive Distribution Agreement with Al- Hikma FZCO for ViaCLYR(TM) Across the Middle East, North Africa, and Adjacent Markets - Accesswire
- 2 months ago - BioLargo Signs Memorandum of Understanding with Aquatech to Accelerate Commercialization of PFAS Treatment Technology - Accesswire
- 2 months ago - BioLargo to Participate in a Town Hall Meeting Hosted by the BioLargo Shareholder Community on Discord on May 5, 2026 - Accesswire